Auvelity is an oral tablet that’s prescribed for depression. It’s a brand-name drug, and it’s not available as a generic medication. The cost of Auvelity can vary, but savings are available.

Axsome Therapeutics posted mixed results for its experimental depression treatment on Tuesday, leading Axsome stock to dive.

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. The FDA has cleared ...

Axsome Therapeutics’ AXSM Auvelity (AXS-05) was launched in the United States in 2022 for the treatment of major depressive disorder (MDD), making it the first approved drug in the company’s ...

Depression is becoming more common among adults and adolescents in the United States, but most are not getting therapy to ...

If you know someone battling depression or Alzheimer’s, Dr. Herriot Tabuteau might just become your new hero. For years, ...

Axsome's Phase 3 trial for solriamfetol in MDD did not meet its primary endpoint, but positive data in severe EDS patients supports plans for a new study in 2025.